a relationship between skeletal demineralization and the development of motor neurone disease. The lead content of iliac crest bone biopsy specimens in 25 patients with motor neurone disease was no greater than that of a control group, but this does not exclude the possibility that lead liberated from bone might affect the motor neurone.
Toxic effects of lead on the nervous system are well recognized. Acute exposure to lead may cause either an acute, asymmetrical motor neuromyopathy with spontaneous recovery ('painters' wrist-drop') or, particularly in children or where the exposure has been severe (Barltrop, 1968) , encephalopathy.
A third variant of neurological system disease, associated with chronic lead toxicity, was described by Kinnier Wilson in 1907. In his cases, a distal symmetrical wasting and weakness of muscles was present, there was evidence of pyramidal tract disturbance in some, and fasciculation was recorded. In 1940 Wilson cited other cases described by earlier authors, and reported two or three other examples. Other instances of motor system disease, associated with lead contact, with varying degrees of upper or lower motor neurone involvement have been reported by Campbell (1955) ; Simpson, Seaton, and Adams (1964) ; Livesley and Sissons (1968); and Campbell and Williams (1968) . In Aran's original description of the progressive muscular atrophy form of motor neurone disease (MND) in 1850, three of his 11 cases had been in contact with lead and two of these had previously suffered from lead poisoning. He drew a distinction between his cases and the 'paralysies saturnines' with which he was familiar. Lead poisoning was common in the 19th century: 1,217 cases of lead poisoning were seen in one year in Paris (Tanquerel des Planches, 1839). Aran did not consider that lead was an aetiological factor in his cases, though he cited a case recorded in the previous century by Van Sweiten in which there was generalized muscular wasting and weakness related to contact with lead. This was probably the first recorded instance of generalized motor system disease associated with lead contact.
In spite of recognition of the hazard to health caused by excessive exposure, lead and its compounds are widely distributed. It has been estimated that the mean adult intake of lead as a result of environmental contamination is 300 ,ug/day (Kehoe, 1961) as opposed to an estimated natural background intake of 20 ,tg/day. The reasons for this, together with evidence of increasing contamination have been summarized by Barltrop (1969) . A recent study (Crawford and Crawford, 1969) has shown that the mean bone lead content was higher in a softwater than a hard-water area, and, although the levels found had been considered harmless, they emphasized that there was little information about long-term exposure to lead or the later effects of a large dose. While the use of lead for water pipes and pigments is decreasing, occupational contact with lead is present in a surprisingly wide variety of pursuits. Gowers (1893) included cases of poisoning from colouring matter in papzr, glazing on cards, hair dyes, and cosmetics in a list of causes of lead poisoning. In the series to be described significant lead contact was discovered in diverse occupations including a labourer in a plastics factory, an analytical chemist, and the domestic fermentation of wine in a lead-glazed vessel. Cases of overt lead poisoning usually occur in hazardous occupations such as the smelting of lead ore, making or burning battery plates, mixing lead pigments, and burning lead paint-for example, in shipyards (Barltrop, 1969) . Sporadic cases from the contamination of food and beverages still occur (Power, Barnes, Nash, and Robinson, 1969) .
After absorption from the gut, lead is deposited initially in the soft tissues such as liver, kidney, and the erythrocytes, but is transferred ultimately to bone. Lead is stored in bone in a biologically inactive form (Kehoe, Thamann, and Cholak, 1933) , and increasing bone lead levels with age have been demonstrated (Minot, 1938; Horiuchi, Horiguchi, and Suekane, 1958) . The biological half-life of lead in sketal tissues is probably at least 12 years (Jaworowski, 1967) , so that prolonged exposure results in increased bone lead concentration which will persist after the original exposure has ceased and the blood lead concentration has returned to normal.
In 1966, Professor Dent drew our attention to the resemblance between conditions associated with hyperparathyroidism and some that we had found to be associated with MND including peptic ulceration, sarcoidosis, bone disease, and a liability to fracture. We have previously reported motor system disease associated with skeletal deformity consequent upon previous poliomyelitis (Campbell, Williams, and Pearce, 1969) . In this study we (Byers and Smith, 1967) . The biopsy thus contained a constant proportion of compact and cancellous bone. The specimen was placed, dry, in a lead-free polystyrene container without further handling, and the incision closed with interrupted sutures. A total of 31 biopsies have been performed without complication. Specimens were obtained from a control series at necropsy on cases of sudden death, using similar techniques. The principal cause of death (65 %) in the control series was cardiovascular accident. The two groups comprised individuals from the same region who were of comparable age, although the mean age of the motor neurone group was slightly less (54 8 years) than of the controls (62-9 years). The specimens were stored at -20°C pending analysis. In 16 patients, two specimens were taken from adjacent sites and the second placed in formalin for histological examination.
The samples were wet-ashed with nitric acid until the residue was colourless. The ash was dissolved in normal hydrochloric acid and the lead concentration determined by polarography after suppression of interference due to ferric ions with hydroxylamine hydrochloride or with ascorbic acid. The calcium content of the same specimen was determined by atomic absorption spectroscopy. Within the limits used, the methods had coefficients of variation of 6l1 % for lead and 3-6% for calcium. By expressing the lead contents in terms of bone calcium, errors due to variations in sampling technique and in the mineralization of the bones were avoided.
RESULTS
LEAD CONTACT In the first 26 patients, studied retrospectively, a record of lead contact was found in two patients, one of whom had had lead poisoning 14 years before the onset of the disease, the source being lead paint in an old house.
Twenty-three of the 74 patients (32%) who were interviewed gave a history of lead contact and the details of this group are given in Table 1 . The cases have been divided into two groups. The first group (11 patients) had had severe exposure to lead (contact in a situation previously reported to cause lead poisoning); the remainder had apparently slight exposure. Only two women gave a history of lead contact, although the male-female ratio of the series was 2-2: 1.
The control group contained 23 women and 51 men. The mean age was 56-2 years compared with the mean age (at onset of disease) of 55 years in the group under study. The incidence of lead contact in the control group is compared with the patient group in Table 2 .
Slight exposure seemed to be equally common in patients and controls, but there was a marked difference in the incidence of severe exposure. The difference between these proportions (15% as against 5 4 %) was statistically significant (P < 0-05).
NATURAL HISTORY OF DISEASE In the group as a whole, the age at onset, mean duration, survival rate, and the ratio between predominantly upper motor neurone, lower motor neurone, and bulbar disease, was similar to other published studies (Partington, 1962; Vejjajiva, Foster, and Miller, 1967) . In contrast, of the 11 patients with major lead contact, six have survived for more than five years and of these five show a similar clinical picture with symmetrical, predominantly lower motor neurone involvement. The five-year survival rate of this group of 11 patients was 54 %, but was only 16o% in the 89 without major contact with lead. The difference between these two groups was significant (P < 0 05).
DISEASE OF BONE A fracture had been sustained by 22 of the 74 patients questioned, at some time before the onset of their neurological disease, and in nine of these the fracture had occurred in the five years preceding onset. Disorders of the axial skeleton were present in 10 other patients (Table 3) . The incidence of gastrectomy, previous peptic ulcer, and poliomyelitis was determined, since these conditions have all previously been implicated in the causation of MND and could have affected bone metabolism. The results obtained from the patients and controls are given in Table 4 . There was no significant difference between the two groups in the percentage of previous fractures, but fracture in the preceding five years (excluding fractures occurring after the first symptom of MND) was significantly more frequent in the patient group (P = 0 05). Disease of the axial skeleton was also more common in the patient group: if the occurrence of either fracture in the last five years or bone disease are considered together, the preponderance in the patient group is highly significant (P < 0 01). (D.B.) .
The values ranged from 8 to 3,500 ,ug/g calcium in the MND group, contrasting with the control group which ranged from 9 to 1,800; the populations were markedly skewed, however, so that the upper limits were represented by few observations in either case and the mean values were almost identical (415 and 410 ,ug/g calcium respectively) (Fig. 1) (Fig. 2) .
We have estimated urinary lead excretion after the administration of chelating agents in three patients (R.P., A.A., and C.E.B.) who had major contact with lead but who have survived for more than five years. Two of these three excreted greater than normal amounts of lead after treatment. These cases may be contrasted with those previously reported in that symptoms of systemic lead toxicity were absent. If exposure to lead were related to motor system disease in these patients, it would seem that neither the duration nor the severity of exposure was critical in the development of the disease.
Seven of our cases appear to form a clinical variant of MND characterized by symmetrical predominantly lower motor neurone weakness, slow progression, and a history of major contact with lead. Treatment with chelating agents seemed to have altered the course of disease in five of these seven patients, and their case histories may be of interest.
CASE 1 C.E.B. presented seven years ago aged 60 years with a three year history of increasing weakness of the limbs commencing in the legs. This had resulted in several falls in one of which he had dislocated his left elbow. He had worked for 40 years as a compositor in a printing works, during which he had handled and cleaned lead type. Initial examination revealed widespread fasciculation and wasting, most marked in the small muscles of the hand. The tendon reflexes were diminished but there were no sensory abnormalities. The urine coproporphyrin concentration was low and it was not thought necessary at that time to determine the blood lead concentration. In view of the strong history of contact with lead he was given 9g of calcium EDTA intravenously during an 11 day period. Urinary lead concentration before therapy was 1-65 Mg/l.; this increased to 58 Mg/l., 24 hours after the first infusion. There was some subjective improvement, and when seen again after 12 months, no progression had taken place. At that time the blood haemoglobin, ESR, serum calcium and phosphate were within normal levels and the serum creatinine phosphokinase was 19 units (normal less than 1 5). The blood lead was 28-3 pg/100 ml.
He has been followed-up regularly since, and no objective increase in weakness has been demonstrated during a four year period. When reassessed six years after onset he still had wasting and weakness of muscle with fasciculation and normal reflexes. Electromyography showed a normal motor nerve conduction velocity R.P. had MND and a history of contact with lead. Marked lead excretion after EDTA rising to 400 mg during the third day. R.R. had frank lead poisoning due to the ingestion of lead arsenite, with basophilia, colic, vomiting, and severe polyneuritis which may have been partly due to arsenic and partly due to lead. A marked excretion of lead for several days after EDTA with complete recovery. through the forearm (50 m/sec) and a remarkably good interference pattem. CASE 2 V.P. presented five years ago aged 36 years with a nine month history of weakness and wasting of muscles, starting in the right hand and spreading to the left hand and the legs five months later. She had worked with lead pigments and glazes during four years at an art college from the age of 18, and admitted to sucking her paint brushes to keep a fine point on them. She had had no contact with lead since that time. In 1960 she developed erythema nodosum and hilar gland lymphadenopathy. A lymph gland biopsy confirmed sarcoidosis. She was treated conservatively and her signs disappeared after six months. She was then well until the onset of motor system disease in 1964.
In 1965 examination revealed predominantly distal wasting and weakness of the upper limbs, right more than left, and slight weakness of the lower legs. There was generalized scanty fasciculation, brisk tendon reflexes, flexor plantar responses, and no bulbar involvement. No impairment of sensation was found.
INVESTIGATIONS The blood haemoglobin, film, ESR, urea, electrolytes, serum calcium, phosphorus and alkaline phosphatase were normal. Serum creatine phosphokinase levels on tw@ occasions were 0-25 and 5-4 units (normal 1-5 vnii-: The serum vitamin B12 level was 800 Hg/l. A musci; biopsy showed the appearances of denervation, and electromyography (Dr. G. Rushworth) suggested pathology of the lower motor neurone and central motor pathways, compatible with the diagnosis of motor neurone disease. The blood lead was 50 9 ,ug/100 ml.
She was given a three-month course of penicillamine 30(0 mg q.d.s. During the next 18 months she improved su ltively. Her reflexes became brisker and the plantar responses extensor, however, although objective measurements of grip showed only slight deterioration in the right hand and none in the left. Impaired muscular power in cold weather with improvement after sitting in a warm room was noted.
In 1966 she became pregnant, and during the last trimester of pregnancy her condition deteriorated slightly. In the six months after delivery (of her seventh child) she noticed, for the first time, impairment of speech and swallowing and was noted to have wasting and fasciculation of the tongue and impaired palatal strength. In the last six months, however (up to December, 1969) there has been no subjective deterioration and only slight impairment of palatal strength.
CASE 3
A.B. presented 16 years ago aged 48 years with a gradually progressive wasting of the hands and arms, right more than left, wrist-drop being the predominant feature. Initial examination revealed a generalized wasting and weakness of muscles with widespread fasciculation.
The reflexes were present but not increased. The weakness was most marked in the extensor muscles of the wrists and ankles.
During the first year her disease had progressed steadily and she had noted increased generalized fasciculation. In 1955 she was given her first course of calcium EDTA and had altogether four courses in that year, a total of 40 g in all. After each course she noted a subjective improvement and between 1956 and the present date has noticed no significant deterioration, except that in 1959 she had thought that her fasciculation was increasing; she was given another 20 g course of calcium EDTA intravenously and has remained unchanged to the present date.
Between 1926 and 1938 she worked as an analytical chemist in a large food company and pipetted lead acetate daily; she admitted that small quantities of this substance were frequently ingested accidentally. CASE 4 R.P. presented 19 years ago aged 58 years with a history of one year's weakness and wasting of muscles affecting mainly the proximal limb musculature. There was also an extensor plantar response on the right, scanty generalized fasciculation, and slight involvement of the small muscles of the hand. There was no sensory abnormality. He had worked as a paint maker, grinding lead compound, for 14 years.
INVESTIGATIONS Blood haemoglobin concentration was 13 9 g%, film normal, CSF protein 40 mg%, blood and CSF WR negative. Blood lead concentration was 80 Htg/100 ml., bone lead concentration (tibial biopsy) 64 p.p.m. wet weight. Electromyographic studies suggested denervation.
He was given alternative employment by his company so that he no longer came in contact with lead, but his condition steadily deteriorated over the next three years. In 1955 he was readmitted and at this time he had difficulty in climbing stairs, and wasting of the distal muscles was more mark-ed; fasciculation persisted.
He was given a total of 10 g calcium EDTA by intravenous infusion, followed by an oral dose of 4 g daily for five weeks. Urine lead excretion after treatment is shown in Fig. 2 . Within three months of discharge the patient was convinced that his deterioration had been halted. In 1956 he was given a further 10 g calcium EDTA intravenously which resulted in subjective improvement. In the last 13 years there has been no deterioration, although he has suffered two myocardial infarctions. When reassessed in 1969 he had generalized wasting, weakness, and fasciculation of muscle, but his grip strength was still 50 % of normal. The iliac crest bone lead concentration was 23 ,ug/g Ca.
CASE 5
A.A. presented a year ago aged 44 years with a six month history of weakness and wasting of the hands, and with slight difficulty in walking during the preceding three months. His symptoms were worse in cold weather. Two years previously he had dropped a weight on his foot and fractured a metatarsal bone. For 14years he hadworked as a labourer in a plastics factory and stated that he had regularly handled and swept up dust containing a lead compound used in the manufacturing process. This is a substance containing 8 % lead by weight but for most of the process it is used in a wetted form.
He had wasting and weakness of the small muscles of the hand, slight weakness of the distal muscles of the lower limbs, depressed tendon reflexes, flexor plantar responses, and scanty generalized fasciculation. There was no sensory loss. INVESTIGATIONS In only one case in the present series was there a past history of frank lead poisoning, and his disease followed a typical course. CASE 7 T.A. aged 58 years, developed wasting, weakness, and fasciculation of the small muscles of the left hand, which spread rapidly to the other limbs. He had farmed all his life, and had no history of industrial lead contact. Thirty-two years previously he and his wife had suffered an acute attack of lead poisoning after drinking homemade sloe and plum wine which had been fermented in an earthenware lead-glazed vessel. Both had severe abdominal colic, constipation, and anaemia but no neurological symptoms, and had made an apparently complete recovery.
When first seen, he presented the typical picture of MND of the progressive muscular atrophy type. The bone lead concentration fell within the middle range of the values obtained in our study (188 Hg/g Ca). His muscular weakness was rapidly progressive, although the bulbar muscles were spared until the terminal stage of the disease. He died in respiratory failure 30 months after his first symptom.
This case history is similar to one recorded by Kinnier Wilson (1940) . His patient developed typical MND eight years after an episode of lead poisoning with wrist-drop (left more than right) from which he made a partial recovery.
DISCUSSION
In the search for aetiological factors in motor neurone disease, the role of lead and other heavy metals has frequently been discussed. Lead has a potent inhibitory effect on the activity of some enzyme symptoms, particularly those with -SH groups, and also affects the metabolism of desoxyribonucleic acid, proteins, and pyruvate (Barltrop, 1969) . In a chronic toxicity study in guinea-pigs (Fullerton, 1966) , it was shown that, while large doses of lead caused death from cerebral oedema, small doses produced chronic wasting and weakness, with widespread motor-nerve demyelination. The only detailed investigation so far reported of heavy metal metabolism in motor neurone disease (Currier and Haerer, 1968) did not demonstrate any increase in urinary lead excretion in a series of 31 patients, nine of whom had had possible lead exposure. Urine lead excretion may be affected by many factors other than the total body lead content, however, and these authors accept that past exposure to toxic metals might initiate a process of neuronal degeneration which might become evident when pathological concentrations of such substances are no longer detectable in the body fluids.
Lead excretion bears only an indirect relationship to the physical signs in cases of lead toxicity, and there is individual variation in tolerance. Previous reports of patients with motor system disease and lead contact treated with chelating agents have been made. Simpson et al. (1964) described a patient in whom the previous symptoms suggested acute lead toxicity and who excreted large amounts of lead after calcium EDTA administration. Livesley and Sissons (1968) reported a case in which there had been episodes of colicky abdominal pain before his neurological symptoms and in whom urinary lead excretion was high (136 ,ug and 170 ,ug per 24 hours). This patient was treated with oral penicillamine, but the lead excretion during treatment was not measured. Brown and Tompsett (1945) reported a case of generalized acute peripheral neuritis occurring in a type-setter who had developed lymphatic leukaemia. Death was due to lead poisoning, and it was thought that lead had been mobilized from the skeletal deposits. Brown (1946) in Glasgow reported 22 cases who had had no industrial lead contact but in whom the blood lead was high, associated with various diseases causing rarefaction of bone, particularly skeletal metastatic carcinoma and widespread reticulosis. He suggested that lead stored in bone might be liberated by an osteolytic process. Mobilization of calcium from the skeleton has been shown to occur with immobilization (Deitrick, Whedon, and Shorr, 1948) , after fracture (Howard, Parson, and Bigham, 1945; Bauer and Carlsson, 1955) , in osteoporosis (Heaney, 1962) , and after poliomyelitis (Whedon and Shorr, 1957) . Lead, or some other toxic heavy metal, might be assumed to behave in a similar manner (Brown, 1946) . In a study of bone loss in ageing, NewtonJohn and Morgan (1968) showed that this commences between 45 and 65 in men; this is of interest in view of the peak age of incidence of MND This study has demonstrated a clinical variant of disease of the motor neurone characterized by symmetrical predominantly lower motor neurone weakness, slow progression, and a history of major contact with lead, and seven of our cases fell into this group. It is suggested that this lead motor neurone damage is the same condition as Kinnier Wilson's amyotrophy of chronic lead poisoning. Treatment with chelating agents has been reported to result in improvement in motor system disease (Livesley and Sissons, 1968) and this would seem to have occurred in at least five of these seven patients. In some of these, the exposure to lead was not immediately apparent, and the clinical features of this group as a whole did not seem to differentiate these cases from those of classical MND. In the absence of any present therapeutic measures likely to improve MND, therapeutic trial of chelating agents in patients with major lead contact is justifiable.
